Reminder – Melanoma Consumer Breakfast this Saturday 6th October 2108

Sat 6th October 2018, 8:00-9:30am All members of the melanoma community are invited to attend a Melanoma Consumer Breakfast. The Breakfast is part of the Australasian Melanoma Conference – which also has great consumer forums. The program is on the website. All bookings can be made via the conference website http://australasianmelanoma.org/

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Townsville’s First Ever Twilight Melanoma March

She will next month join Townsville’s first ever twilight Melanoma March in honour of her mother, Gina Sellen, who lost her battle against the deadly cancer in 2016.

Cancer in the News

Feature Articles

Choroidal melanoma therapy offers promising treatment option

Source: Healio, April 2019 HILADELPHIA — A choroidal melanoma therapy has been shown to reduce tumor thickness and preserve best corrected visual acuity in patients participating in a phase 1b/2 study, according to a speaker here. AU-011 (Aura Biosciences) has been administered to 30 patients with choroidal melanoma, demonstrating 87% tumor control in subjects with a single […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

AstraZeneca taps microbiome specialist Seres for I-O support

Source: Fierce Biotech, April 2019 AstraZeneca has teamed up with Seres Therapeutics to explore whether microbiome therapeutics can increase the efficacy of cancer immunotherapies. The deal will see AstraZeneca pay $20 million to collaborate with Seres and test SER-401 in combination with its oncology assets. Seres firmed up its interest in using microbiome therapeutics in immuno-oncology when […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Patient videos for those about to start immunotherapy

February 2019 A group of researchers at Peter Mac have spent the past year working with patients, family members, nurses and medical oncologists to develop a series of videos for patients about to start immunotherapy. We developed these videos “brand free” so they are suitable for use by all patients, irrespective of the type of […]

READ MORE >

Posted in Melanoma News, Patients, Other Resources, Patient Stories, Publications

Safety Comparison of Two Dosing Regimens for Nivolumab Plus Ipilimumab in Advanced Melanoma

Source: The ASCO Post, April 2019 In the phase IIIb/IV CheckMate 511 study reported by Lebbé et al in the Journal of Clinical Oncology, a regimen of nivolumab at 3 mg/kg plus ipilimumab at 1 mg/kg (NIVO3+IPI1) was found to significantly reduce the incidence of treatment-related grade 3 to 5 adverse events compared with nivolumab at 1 […]

READ MORE >

Posted in Melanoma News, Health Professionals, Clinical Trials